City

Boston (2)

New York (1)

San Antonio (1)

Condition

AML (2)

CML (2)

ALL (1)

Hematologic Malignancy (1)

Hodgkin's Lymphoma (1)

MDS (1)

Multiple Myeloma (1)

Myeloproliferative Disorders (1)

NHL (1)

Overall Status

Completed (2)

Phase

n/a (1)

phase 1 (1)

Sponsor

Dana-Farber Cancer Institute (1)

Synta Pharmaceuticals Corp. (1)

Collaborator

Brigham and Women's Hospital (1)

Intervention

cd+8 t cell depletion (1)

sta-9090 (ganetespib) (1)

Study Documents

Intervention Type

device (1)

drug (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

cml

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

AML, CML, MDS Trial in Boston, New York, San Antonio (STA-9090 (ganetespib))

Completed

AML
+3 more

STA-9090 (ganetespib)

Boston, Massachusetts
+2 more

Sep 17, 2014

Hematologic Malignancy, AML, ALL Trial in Boston (CD+8 T cell depletion)

Completed

Hematologic Malignancy
+6 more

CD+8 T cell depletion

Boston, Massachusetts
+1 more

Mar 15, 2012